NEW YORK, June 20, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of GoodRx Holdings, Inc. (NASDAQ: GDRX). Shareholders who purchased shares of GDRX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/goodrx-loss-submission-form/?id=86296&from=4 CLASS PERIOD: September 23, 2020 to ...

文章核心观点 - 公司GoodRx经营一个药品价格比较平台,通过与药品福利管理公司(PBM)合作,为消费者提供药品优惠券和折扣 [4] - 公司在IPO和后续期间一直强调与药店的良好关系是其业务计划的重要组成部分,特别是强调了与Kroger的"Kroger Rx Savings Club"合作 [5] - 但公司未告知投资者,Kroger(占公司近25%的处方交易收入)可能单方面拒绝接受公司的折扣优惠这一重大风险 [5] 关键事件总结 1) 2022年5月,公司披露一家连锁超市(后确认为Kroger)采取行动影响了大部分PBM折扣的接受,这可能导致公司第二季度收入损失约3000万美元 [6] 2) 2022年11月,公司进一步披露Kroger问题对第三季度和第四季度的收入影响分别约4000万美元和4500-5000万美元 [8] 3) 公司表示正在寻求与药店建立合同关系,以防止未来出现类似的中断 [8] 股价变化 1) 2022年5月10日,公司股价下跌超过25%,从10.75美元跌至7.97美元 [7] 2) 2022年11月9日,公司股价再次下跌超过22%,从5.24美元跌至4.06美元 [9]

NEW YORK, June 19, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GoodRx Holdings, Inc. (NASDAQ: GDRX) between September 23, 2020 and November 8, 2022, both dates inclusive (the “Class Period”), of the important June 21, 2024 lead plaintiff deadline. SO WHAT: If you purchased GoodRx common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrang ...

SAN DIEGO, June 18, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that the GoodRx class action lawsuit seeks to represent purchasers or acquirers of GoodRx Holdings, Inc. (NASDAQ: GDRX) common stock between September 23, 2020 and November 8, 2022, inclusive (the “Class Period”) have until this Friday, June 21, 2024 to seek appointment as lead plaintiff of the GoodRx class action lawsuit. Captioned Barsuli v. GoodRx Holdings, Inc., No. 24-cv-03282 (C.D. Cal.), the GoodRx class action la ...

NEW YORK, June 18, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of GoodRx Holdings, Inc. (NASDAQ: GDRX). Shareholders who purchased shares of GDRX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/goodrx-loss-submission-form/?id=85772&from=3 CLASS PERIOD: September 23, 202 ...

LOS ANGELES, June 18, 2024 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GoodRx Holdings, Inc. (“GoodRx” or “the Company”) (NASDAQ: GDRX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company’s securities between September 23, 2020 and November 8, 2022, inclusive (the “Class ...

RADNOR, Pa., June 17, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against GoodRx Holdings, Inc. (NASDAQ: GDRX) ("GoodRx" or the "Company") on behalf of investors who purchased or acquired GoodRx common stock between September 23, 2020, and November 8, 2022, inclusive (the "Class Period"). This action, captioned Barsuli v. GoodRx Holdings, Inc., et al., Case No. Case 2:24-cv-03282- DDP-AJR was filed ...

文章核心观点 - GoodRx Holdings, Inc.(NASDAQ: GDRX)的股东在2020年9月23日至2022年11月8日期间购买公司股票,可能会受到虚假和/或误导性陈述的影响 [1][2][3] - 公司声称Kroger药店占其总收入的5%以下,但实际上Kroger药店占公司主要收入来源处方交易收入的近25% [3] - Kroger可以单方面停止接受GoodRx折扣,从而切断公司在Kroger药店的部分或全部收入 [3] 公司相关内容 - GoodRx Holdings, Inc.是一家提供处方药优惠券和价格比较服务的公司 [1][2][3] - 公司在2020年9月23日至2022年11月8日期间发布了虚假和/或误导性陈述 [3] - 公司主要收入来源是处方交易收入 [3] 行业相关内容 - 公司主要通过与药店合作提供优惠券和价格比较服务获得收入 [3] - Kroger是公司重要的合作伙伴,占公司总收入的近25% [3]

NEW YORK, June 12, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against GoodRx Holdings, Inc. ("GoodRx" or the "Company") (NASDAQ:GDRX) and reminds investors of the June 21, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In G ...

NEW YORK, June 12, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ: GDRX) and reminds investors of the June 21, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In ...